In vitro antimalarial susceptibility profile of Plasmodium falciparum isolates in the BEI Resources repository
Open Access
- 8 October 2024
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 68 (10) , e0118923
Abstract
BEI Resources, a National Institute of Allergy and Infectious Diseases-funded program managed by the American Type Culture Collection, serves researchers worldwide through the provision of a centralized repository for the acquisition, production, characterization, preservation, storage, and distribution of standardized biological resources targeting National Institutes of Health priority pathogens including bacteria, viruses, pathogenic fungi, and parasitic protozoa. These reference materials are critical for the development of diagnostics, vaccines, and therapeutics and are available to qualified registered investigators and institutions worldwide. Bioresources within BEI include well-characterized malaria isolates as part of the Malaria Research and Reference Reagent Resource Center (MR4). These isolates are critical for screening antimalarial compounds, conducting drug resistance studies, and for resistance surveillance and management. In our efforts to enhance the characterization of MR4 P. falciparum isolates, we measured antimalarial susceptibility of >100 isolates against a panel of standard antimalarial compounds. Our results provide valuable information to assist current and prospective users of the BEI Resources repository in making data-driven requests of isolates to meet their research needs.Keywords
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (75N93024C00001)
This publication has 47 references indexed in Scilit:
- Dissection of haplotype-specific drug response phenotypes in multiclonal malaria isolatesInternational Journal for Parasitology: Drugs and Drug Resistance, 2021
- Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions – India and sub-Saharan AfricaInternational Journal for Parasitology: Drugs and Drug Resistance, 2021
- Impact of Field Isolate Identified Nonsynonymous Single Nucleotide Polymorphisms on Plasmodium falciparum Equilibrative Nucleoside Transporter 1 Inhibitor EfficacyACS Infectious Diseases, 2020
- A molecular marker of artemisinin-resistant Plasmodium falciparum malariaNature, 2013
- Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studiesThe Lancet Infectious Diseases, 2013
- Mapping ‘partially resistant’, ‘fully resistant’, and ‘super resistant’ malariaTrends in Parasitology, 2013
- Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal studyThe Lancet, 2012
- Parasites bearing a single copy of the multi-drug resistance gene (pfmdr-1) with wild-type SNPs predominate amongst Plasmodium falciparum isolates from MalawiActa Tropica, 2009
- A drug-selected Plasmodium falciparum lacking the need for conventional electron transportMolecular and Biochemical Parasitology, 2008
- Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policiesDrug Resistance Updates, 2004